Accretion Pharmaceuticals IPO : Key Performance Indicators, PE Ratio, EPS, ROE, ROCE & RoNW
The Company Key Performance Indicates the pre-issue EPS of ₹ 9.69 and post-issue EPS of ₹ 3.49 for FY24. The pre-issue P/E ratio is 10.42x, while the post-issue P/E ratio is 28.97x against the Industry P/E ratio is 28x. The company's ROCE for FY24 is 36.73%, ROE for FY24 is 72.47% and RoNW is 72.47%. The Annualised EPS based on the latest financial data is ₹ 11.65 and PE ratio is 8.66x. These metrics suggest that the IPO is fairly priced.
Key Performance Indicator |
|||||||||||
| KPI | Values | ||||||||||
| EPS Pre IPO (Rs.) | ₹ 9.69 | ||||||||||
| EPS Post IPO (Rs.) | ₹ 3.49 | ||||||||||
| P/E Pre IPO | 10.42 | ||||||||||
| P/E Post IPO | 28.97 | ||||||||||
| ROE | 72.47 % | ||||||||||
| ROCE | 36.73 % | ||||||||||
| P/BV | 5.91 | ||||||||||
| Debt/Equity | 2.52 | ||||||||||
| RoNW | 72.47 % | ||||||||||
Copyright @2020 Design & Developed by Info Web Software